MAGGIC Risk Model Predicts Adverse Events and Left Ventricular Remodeling in Non-Ischemic Dilated Cardiomyopathy

Yang Dong1, Dongfei Wang1, Jialan Lv1

  • 1Department of Cardiology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, People's Republic of China.

Insights

The Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) risk score predicts adverse events and left ventricular remodeling in dilated cardiomyopathy patients. This score aids in assessing prognosis and understanding disease progression.

Area of Science:

  • Cardiology
  • Heart Failure Research
  • Clinical Prognostics

Background:

  • Dilated cardiomyopathy (DCM) is a significant cause of heart failure.
  • Accurate prognostic models are crucial for managing DCM patients.
  • Left ventricular remodeling is a key factor in DCM progression and outcomes.

Purpose of the Study:

  • To evaluate the prognostic value of the Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) risk score in patients with dilated cardiomyopathy.
  • To investigate the relationship between the MAGGIC risk score and left ventricular remodeling in DCM.

Main Methods:

  • Prospective study of 114 DCM patients with clinical assessments and echocardiography.
  • MAGGIC risk score calculation and follow-up for adverse events (mortality, heart failure rehospitalization).
  • Assessment of left ventricular remodeling and statistical analysis using Cox regression and ROC curves.

Main Results:

  • The MAGGIC risk score independently predicted adverse events, including all-cause mortality and heart failure rehospitalization.
  • A significant correlation was found between the MAGGIC risk score and changes in left ventricular remodeling parameters.
  • The model showed modest discrimination for adverse events and left ventricular remodeling (AUC 0.6-0.7).

Conclusions:

  • The MAGGIC risk score is associated with adverse clinical outcomes in dilated cardiomyopathy.
  • The MAGGIC risk score also correlates with left ventricular remodeling, a marker of disease severity.
  • This risk score can aid in predicting prognosis and monitoring disease progression in DCM.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
193
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
128
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
280
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
173
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
250
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
184